Agustin A. M.
- Country
- Spain
- Department
- Gastroenterology Hepatology
Research Overview
- Phase III Randomized Double‑Blind Placebo‑Controlled Study of Oral Elafibranor 120 mg in Adults with Primary Sclerosing Cholangitis
- Efficacy and Safety Evaluation of GSK4532990 in Adults with Alcohol-Related Liver Disease: A Phase 2, Double-Blind, Placebo-Controlled, Dose-Finding Study
- Evaluation of Safety, Efficacy, and Immunogenicity of Sequential Bepirovirsen and GSKVX000000008866 in Chronic Hepatitis B Patients on Nucleos(t)ide Analogue Therapy
Data & Insights
Has run more than one trial at 92 of 243 partner sites.
Specializations
Liver Cirrhosis & Portal Hypertension
Specializes in investigating therapeutic approaches for cirrhotic liver disease and portal hypertension, with particular attention to decompensated conditions and clinical complications.
- Portal pressure management
- Cirrhosis decompensation
- Hepatic encephalopathy
Focuses on innovative combination therapies and novel compounds for managing cirrhosis-related complications.
Metabolic Liver Disease
Conducts research in non-alcoholic steatohepatitis (NASH) and obesity-related liver conditions, exploring therapeutic interventions for liver fat reduction and fibrosis improvement.
- NASH resolution strategies
- Liver fat reduction
- Metabolic dysfunction
Evaluates novel therapeutic agents targeting metabolic liver disease progression.
Advanced Liver Therapeutics
Investigates cutting-edge treatments including cell therapy and microbiome-based interventions for various liver conditions, with emphasis on innovative therapeutic approaches.
- Autologous cell therapies
- Fecal microbiome transplantation
- Viral hepatitis treatments
Explores emerging therapeutic modalities for chronic liver diseases and their complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.